BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/21/2021 3:12:07 AM | Browse: 436 | Download: 597
 |
Received |
|
2020-06-29 10:26 |
|
Peer-Review Started |
|
2020-06-29 10:27 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-10-21 20:24 |
|
Revised |
|
2020-11-16 08:43 |
|
Second Decision |
|
2020-11-26 10:17 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-11-29 22:20 |
|
Articles in Press |
|
2020-11-29 22:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-12-07 08:14 |
|
Typeset the Manuscript |
|
2021-01-18 06:19 |
|
Publish the Manuscript Online |
|
2021-01-21 03:12 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Pancreatic β cell regeneration induced by clinical and preclinical agents
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Kang-Li Wang, Ming Tao, Tian-Jiao Wei and Rui Wei |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the National Key Research and Development Program of China |
2016YFA0100501 |
| the National Natural Science Foundation of China |
81770768 and 81970671 |
| the Natural Science Foundation of Beijing |
7192225 |
|
| Corresponding Author |
Rui Wei, MD, PhD, Research Associate, Department of Endocrinology and Metabolism, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, China. weirui@bjmu.edu.cn |
| Key Words |
β cell regeneration; β cell dedifferentiation; Cell proliferation; Pancreatic progenitors; α-to-β cell transdifferentiation; Enteroendocrine progenitor cells |
| Core Tip |
Pancreatic regeneration is a potential therapeutic strategy for β cell recovery in diabetes. Previous studies have focused on the various cell types and different strategies for islet regeneration. However, how far this is from clinical application has not been fully elucidated. In this review, we focus on the clinical and preclinical agents used in different approaches. The clinical potential and disadvantages of the various approaches are discussed, and some suggestions are made for future perspectives. |
| Publish Date |
2021-01-21 03:12 |
| Citation |
Wang KL, Tao M, Wei TJ, Wei R. Pancreatic β cell regeneration induced by clinical and preclinical agents. World J Stem Cells 2021; 13(1): 64-77 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i1/64.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i1.64 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
